Monday, 30 December 2013

Landmark ADHD study backed drugs over therapy at a cost: report



by Margaret Farley Steele, Healthday Reporter

Landmark ADHD study backed drugs over therapy at a cost: report


Children denied counseling may have lost out, experts say.


(HealthDay)—Many children with attention-deficit hyperactivity disorder (ADHD) may have missed out on valuable counseling because of a widely touted study that concluded stimulants such as Ritalin or Adderall were more effective for treating the disorder than medication plus behavioral therapies, experts say.


That 20-year-old study, funded with $11 million from the U.S. National Institute of Mental Health, concluded that the medications outperformed a combination of stimulants plus skills-training therapy or therapy alone as a long-term treatment.


But now experts, who include some of the study's authors, think that relying on such a narrow avenue of treatment may deprive children, their families and their teachers of effective strategies for coping with ADHD, The New York Times reported Monday.


"I hope it didn't do irreparable damage," study co-author Dr. Lily Hechtman, of McGill University in Montreal, told the Times. "The people who pay the price in the end [are] the kids. That's the biggest tragedy in all of this."


Professionals worry that the findings have overshadowed the long-term benefits of school- and family-based skills programs. The original findings also gave pharmaceutical companies a significant marketing tool—now more than two-thirds of American kids with ADHD take medication for the condition. And insurers have also used the study to deny coverage of psychosocial therapy, which costs more than daily medication but may deliver longer-lasting benefits, according to the Times.


According to the news report, an insured family might pay $200 a year for stimulants, while individual or family therapy can be time-consuming and expensive, reaching $1,000 or more.


About 8 percent of U.S. children are diagnosed with ADHD before the age of 18, according to the U.S. Centers for Disease Control and Prevention. People with the condition may have trouble paying attention, often act without thinking and may be hyperactive, making school work and the acquisition of essential skills extremely difficult.


Drugs that improve attention make it easier for the children to learn, but when the drug wears off or if the users stop taking the drugs, benefits are less apparent.


Some experts today cite limitations of the original study, which looked at classic ADHD symptoms such as forgetfulness and restlessness over academic achievement and family and peer interactions. This gave medication an edge over therapy from the get-go, several people involved with the study told the Times.


"When you asked families what they really liked, they liked combined treatment," said Dr. Peter Jensen, formerly head of child psychiatry at the National Institute of Mental Health (NIMH) who oversaw the study for the institute. "They didn't not like medicine, but they valued skill training. What doctors think are the best outcomes and what families think are the best outcomes aren't always the same thing."


For the study, the NIMH enlisted more than a dozen experts to determine the best ADHD treatment. Close to 600 children with ADHD, aged 7 to 9, received one of four treatments for more than a year: medication alone, behavioral therapy alone, a combination of both treatments, or nothing in addition to their current treatment.


The study authors concluded in a 1999 paper that medication was superior to behavioral treatment.


But when the children in the study were followed into adulthood, the study results looked less conclusive. Use of any treatment "does not predict functioning six to eight years later," a follow-up paper from the study determined, the Times reported.



More information: The U.S. National Institute of Mental Health has more about ADHD.


Copyright © 2013 HealthDay. All rights reserved.


Medical Xpress on facebook

Related Stories


Continued increases in ADHD diagnoses and treatment with medication among US children


Nov 22, 2013



A new study published in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) found that an estimated two million more children in the United States (U.S.) have been diagnosed with attention-def ...



CDC: More than one in 10 kids diagnosed with ADHD


Nov 26, 2013



(HealthDay)—More than one in 10 children and adolescents are diagnosed with attention-deficit/hyperactivity disorder (ADHD), an increase of 42 percent in less than a decade, according to a study published ...



Parents' goals guide ADHD treatment choice


Sep 02, 2013



(HealthDay)—Parents' goals for treating their child's attention-deficit hyperactivity disorder (ADHD) tend to steer the treatment in a distinct direction, new research shows.



90 percent of pediatric specialists not following clinical guidelines when treating preschoolers with ADHD


May 04, 2013



A recent study by pediatricians from the Cohen Children's Medical Center of New York examined to what extent pediatric physicians adhere to American Academy of Pediatrics (AAP) clinical guidelines regarding pharmacotherapy ...



Study evaluates treating mothers with ADHD to improve outcomes in kids


Oct 18, 2012



(Medical Xpress)—University of Illinois at Chicago researchers are conducting a study to determine if treating mothers with Attention Deficit Hyperactivity Disorder—either with medication or parent training—will help ...



Recommended for you


FDA warns of dangerous erections from ADHD drugs


Dec 17, 2013



The Food and Drug Administration is warning that a stimulant used in treatments for the childhood condition attention deficit-hyperactivity disorder can trigger painful, long-lasting erections in rare cases.





Breaking the link between ADHD and addiction


Dec 06, 2013



Adult sufferers of ADHD are two to three times more likely to experience substance abuse or dependence, but a research project which will map the genetic markers of the condition will help sever ties with ...





Study correlates ADHD and secondhand smoke


Dec 06, 2013



(Medical Xpress)—Duke Medicine has established a new research program to investigate the relationship between exposure to environmental tobacco smoke during pregnancy and childhood and attention deficit ...





MRI technique reveals low brain iron in ADHD patients


Dec 02, 2013



Magnetic resonance imaging (MRI) provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder (ADHD), according to a study being presented today ...



Genetic discovery could increase understanding of ADHD


Nov 28, 2013



(Medical Xpress)—Scientists at Trinity College Dublin have discovered that a mutation in a single gene involved in the functioning of the brain's nervous system can lead to hyperactivity symptoms that are characteristic ...



ADHD linked to social and economic disadvantage


Nov 26, 2013



Scientists have found evidence of a link between social and economic status and childhood attention deficit disorder (ADHD) in the UK.



User comments







by Margaret Farley Steele, Healthday Reporter

Landmark ADHD study backed drugs over therapy at a cost: report


Children denied counseling may have lost out, experts say.


(HealthDay)—Many children with attention-deficit hyperactivity disorder (ADHD) may have missed out on valuable counseling because of a widely touted study that concluded stimulants such as Ritalin or Adderall were more effective for treating the disorder than medication plus behavioral therapies, experts say.


That 20-year-old study, funded with $11 million from the U.S. National Institute of Mental Health, concluded that the medications outperformed a combination of stimulants plus skills-training therapy or therapy alone as a long-term treatment.


But now experts, who include some of the study's authors, think that relying on such a narrow avenue of treatment may deprive children, their families and their teachers of effective strategies for coping with ADHD, The New York Times reported Monday.


"I hope it didn't do irreparable damage," study co-author Dr. Lily Hechtman, of McGill University in Montreal, told the Times. "The people who pay the price in the end [are] the kids. That's the biggest tragedy in all of this."


Professionals worry that the findings have overshadowed the long-term benefits of school- and family-based skills programs. The original findings also gave pharmaceutical companies a significant marketing tool—now more than two-thirds of American kids with ADHD take medication for the condition. And insurers have also used the study to deny coverage of psychosocial therapy, which costs more than daily medication but may deliver longer-lasting benefits, according to the Times.


According to the news report, an insured family might pay $200 a year for stimulants, while individual or family therapy can be time-consuming and expensive, reaching $1,000 or more.


About 8 percent of U.S. children are diagnosed with ADHD before the age of 18, according to the U.S. Centers for Disease Control and Prevention. People with the condition may have trouble paying attention, often act without thinking and may be hyperactive, making school work and the acquisition of essential skills extremely difficult.


Drugs that improve attention make it easier for the children to learn, but when the drug wears off or if the users stop taking the drugs, benefits are less apparent.


Some experts today cite limitations of the original study, which looked at classic ADHD symptoms such as forgetfulness and restlessness over academic achievement and family and peer interactions. This gave medication an edge over therapy from the get-go, several people involved with the study told the Times.


"When you asked families what they really liked, they liked combined treatment," said Dr. Peter Jensen, formerly head of child psychiatry at the National Institute of Mental Health (NIMH) who oversaw the study for the institute. "They didn't not like medicine, but they valued skill training. What doctors think are the best outcomes and what families think are the best outcomes aren't always the same thing."


For the study, the NIMH enlisted more than a dozen experts to determine the best ADHD treatment. Close to 600 children with ADHD, aged 7 to 9, received one of four treatments for more than a year: medication alone, behavioral therapy alone, a combination of both treatments, or nothing in addition to their current treatment.


The study authors concluded in a 1999 paper that medication was superior to behavioral treatment.


But when the children in the study were followed into adulthood, the study results looked less conclusive. Use of any treatment "does not predict functioning six to eight years later," a follow-up paper from the study determined, the Times reported.



More information: The U.S. National Institute of Mental Health has more about ADHD.


Copyright © 2013 HealthDay. All rights reserved.


Medical Xpress on facebook

Related Stories


Continued increases in ADHD diagnoses and treatment with medication among US children


Nov 22, 2013



A new study published in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) found that an estimated two million more children in the United States (U.S.) have been diagnosed with attention-def ...



CDC: More than one in 10 kids diagnosed with ADHD


Nov 26, 2013



(HealthDay)—More than one in 10 children and adolescents are diagnosed with attention-deficit/hyperactivity disorder (ADHD), an increase of 42 percent in less than a decade, according to a study published ...



Parents' goals guide ADHD treatment choice


Sep 02, 2013



(HealthDay)—Parents' goals for treating their child's attention-deficit hyperactivity disorder (ADHD) tend to steer the treatment in a distinct direction, new research shows.



90 percent of pediatric specialists not following clinical guidelines when treating preschoolers with ADHD


May 04, 2013



A recent study by pediatricians from the Cohen Children's Medical Center of New York examined to what extent pediatric physicians adhere to American Academy of Pediatrics (AAP) clinical guidelines regarding pharmacotherapy ...



Study evaluates treating mothers with ADHD to improve outcomes in kids


Oct 18, 2012



(Medical Xpress)—University of Illinois at Chicago researchers are conducting a study to determine if treating mothers with Attention Deficit Hyperactivity Disorder—either with medication or parent training—will help ...



Recommended for you


FDA warns of dangerous erections from ADHD drugs


Dec 17, 2013



The Food and Drug Administration is warning that a stimulant used in treatments for the childhood condition attention deficit-hyperactivity disorder can trigger painful, long-lasting erections in rare cases.





Breaking the link between ADHD and addiction


Dec 06, 2013



Adult sufferers of ADHD are two to three times more likely to experience substance abuse or dependence, but a research project which will map the genetic markers of the condition will help sever ties with ...





Study correlates ADHD and secondhand smoke


Dec 06, 2013



(Medical Xpress)—Duke Medicine has established a new research program to investigate the relationship between exposure to environmental tobacco smoke during pregnancy and childhood and attention deficit ...





MRI technique reveals low brain iron in ADHD patients


Dec 02, 2013



Magnetic resonance imaging (MRI) provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder (ADHD), according to a study being presented today ...



Genetic discovery could increase understanding of ADHD


Nov 28, 2013



(Medical Xpress)—Scientists at Trinity College Dublin have discovered that a mutation in a single gene involved in the functioning of the brain's nervous system can lead to hyperactivity symptoms that are characteristic ...



ADHD linked to social and economic disadvantage


Nov 26, 2013



Scientists have found evidence of a link between social and economic status and childhood attention deficit disorder (ADHD) in the UK.



User comments








Categories:

0 comments:

Post a Comment